Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) ROCE % : -2.50% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Fine Foods & Pharmaceuticals NTM SpA ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Fine Foods & Pharmaceuticals NTM SpA's annualized ROCE % for the quarter that ended in Dec. 2023 was -2.50%.

Fine Foods & Pharmaceuticals NTM SpA ROCE % Historical Data

The historical data trend for Fine Foods & Pharmaceuticals NTM SpA's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fine Foods & Pharmaceuticals NTM SpA ROCE % Chart

Fine Foods & Pharmaceuticals NTM SpA Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

0.38

11.01

-2.21

-5.95

1.66

Fine Foods & Pharmaceuticals NTM SpA Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															-3.72	9.96	-6.13	3.73	-2.50

Fine Foods & Pharmaceuticals NTM SpA ROCE % Calculation

Fine Foods & Pharmaceuticals NTM SpA's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	2.952	/	( ( (299.821 - 84.034)	+	(241.562 - 101.378) )	/ 2 )
	=	2.952	/	( (215.787	+	140.184)	/ 2 )
	=	2.952	/	177.9855
	=	1.66 %

Fine Foods & Pharmaceuticals NTM SpA's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-4.196	/	( ( (272.654 - 76.997)	+	(241.562 - 101.378) )	/ 2 )
	=	-4.196	/	( ( 195.657	+	140.184 )	/ 2 )
	=	-4.196	/	167.9205
	=	-2.50 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Fine Foods & Pharmaceuticals NTM SpA ROCE % Related Terms

Thank you for viewing the detailed overview of Fine Foods & Pharmaceuticals NTM SpA's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Fine Foods & Pharmaceuticals NTM SpA (MIL:FF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

9S5:Germany

Address

Via Berlino, 39, Verdellino, Zingonia, Bergamo, ITA, 24040

Website

https://www.finefoods.it

Fine Foods & Pharmaceuticals NTM SpA is engaged in contract development and manufacturing of pharmaceuticals, nutraceuticals, and medical devices in solid oral forms. The company produces pharmaceutical products such as powders and granules, tablets, film tablets, and hard gelatin capsules, packed in sachets, blisters, and pillows.